DRUG · Bright Minds Biosciences Inc.
$71.13
-0.83 (-1.15%)
At close · Jul 29
Market Cap
$706.08M
Shares
9.81M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$71.96
Open$72.11
Day$70.20–73.01
52W$31.80–123.75
Avg vol 30d302K
Short int956K · 9.7% float · 3.1d
Short vol68%
DataMar 2021–Jul 2026
Up next
FQ4-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−5%
below
Price vs 50-day avg
−0%
below
RSI (14)
49
neutral
MACD trend
Negative
52-week position
44%
mid-range
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+9%
trailing
6-month return
−8%
trailing
YTD return
−8%
this year
Relative strength
−16%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $72 › 200d $75 — 200d above 50d
Institutional flow
Accumulating
7 of 93 funds reported for Jun 30 · net +93 sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
9.74% of float · ▲ +0.3% MoM · 3.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
93 holders — near 3-yr high, broad support
Squeeze score
68
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
71%
annualized · 1-yr
Max drawdown
−38%
past year
ATR
6.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−5%
Neutral
Price vs 50-day avg
−0%
Neutral
RSI (14)
49
Neutral
MACD trend
Negative
Bearish
52-week position
44%
Neutral
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $72 › 200d $75 — 200d above 50d
Institutional flow
Accumulating
7 of 93 funds reported for Jun 30 · net +93 sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
9.74% of float · ▲ +0.3% MoM · 3.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
93 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $32
Now $72 · 44%
52-wk high $124
vs 200-day avg -5%
vs 50-day avg 0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DRUG
this stock
Bright Minds Biosciences Inc.
|
$706.08M | -7.8% | — | — | 9.7% |
|
ONC
BeOne Medicines Ltd.
|
$474.96B | +8.8% | +22179.2% | 966.6 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$124.46B | +8.2% | +46.2% | 29.1 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$72.88B | -9.8% | +20.8% | 17.0 | 3.3% |
|
ARGX
Argenx SE
|
$54.57B | +3.7% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DRUG | -3.6% | +9.4% | -8.5% | +2.5% | -7.8% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | -2.6% | +9.4% | -15.9% | +3.3% | -16.4% |